Berlin-Chemie is an innovative and international pharmaceutical company.
Its history dates back to 1890 in Berlin-Adlershof, when Johannes Kahlbaum founded the company that would eventually become Berlin-Chemie.
In 1992, Berlin-Chemie became part of the globally operating Menarini Group. Within the Menarini group, Berlin-Chemie oversees the pharmaceutical business in Germany, Eastern Europe, and the CIS (Commonwealth of Independent States) region.
We aim to address gaps in medical education and improve patient outcomes
In this capacity, Berlin-Chemie supplies medicines to more than 30 countries and has subsidiaries in over 26 of them.
At Berlin-Chemie we are committed to improving patient health outcomes. Our collaborative partnerships with healthcare professionals enable specialist insight into new treatment patterns and developments, to address unmet medical needs. By providing the Online Academy, we aim to address gaps in medical education and improve patient outcomes through targeted multidisciplinary educational content.

Berlin-Chemie Online Academy offers a comprehensive live and on-demand webinar programme, delivered by industry experts, to provide insight into the latest medical research and best practices. Topics covered in the Online Academy’s extensive medical education content library include the following.
- Professional insights and opinions on current industry news and developments
- Latest medical research, data, and evidence
- Real-world evidence
- Patient case studies
- Clinical trial updates
- Congress reports
We offer dedicated medical content, webinars, and resources across multiple disciplines.